The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pomalidomide plus low-dose dexamethasone (POM + LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM): Impact of cytogenetics in MM-003.
Hartmut Goldschmidt
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Meletios A. Dimopoulos
Consultant or Advisory Role - Celgene; Ortho Biotech
Honoraria - Celgene
Research Funding - Genesis Pharmaceuticals
Katja C. Weisel
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Philippe Moreau
Consultant or Advisory Role - Celgene; Janssen; Millennium
Honoraria - Celgene; Janssen; Millennium
Martha Lacy
Research Funding - Celgene
Kevin W. Song
Consultant or Advisory Role - Celgene; Janssen
Honoraria - Celgene; Janssen
Research Funding - Celgene; Janssen
Michel Delforge
Consultant or Advisory Role - Celgene; Janssen
Honoraria - Celgene; Janssen
Lionel Karlin
Consultant or Advisory Role - Celgene
Honoraria - Celgene; Janssen
Expert Testimony - Celgene
Other Remuneration - Celgene; Janssen
Anne Banos
No relevant relationships to disclose
Albert Oriol Rocafiguera
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Xin Yu
Employment or Leadership Position - Celgene
Lars Sternas
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Christian Jacques
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Mohamed H. Zaki
Research Funding - Celgene
Jesùs F. San-Miguel
Consultant or Advisory Role - Celgene; Janssen; Millennium; Novartis; Onyx
Honoraria - Celgene; Janssen; Millennium; Novartis; Onyx